Sort by
Keyphrases
G Protein-coupled Receptor
60%
Neurotherapeutics
48%
Non-catechol
40%
Leydig Cells
36%
Steroidogenesis
36%
G Protein
35%
Mitochondria
34%
Mitochondrium
34%
Dopamine D1 Receptor
32%
Serotonin 2A Receptor (5-HT2AR)
31%
Steroidogenic Acute Regulatory Protein (StAR)
28%
D1 Receptor
27%
Schizophrenia
25%
5-HT2A Receptor
25%
Arrestin
23%
Receptor Agonist
23%
Lipid Rafts
23%
5-HT2C Receptor
23%
Substance Use Disorder
22%
Synthetic Evaluation
18%
Dopamine D1 Agonists
18%
Pharmacological Evaluation
18%
Dopamine Receptor
18%
Reactive Oxygen Species
18%
Caveolin-1 (Cav-1)
18%
GPR52
18%
Catechol
18%
Receptor Signaling
18%
Drug Action
16%
Drug Discovery
15%
Small Molecules
15%
Drug-like
15%
Biased Agonist
14%
Chemical Genetics
13%
Adenylyl Cyclase
13%
Psychiatric Disorders
13%
Neurological Diseases
13%
Ligand-receptor Binding
12%
Clozapine-N-oxide
12%
Mitochondrial Function
12%
Remote Control
12%
Orphan Receptor
11%
Caveolin
11%
S6 Kinase 1 (S6K1)
11%
Atypical Antipsychotics
11%
Cellular Signaling
11%
Therapeutic Target
11%
Neurodevelopmental Disorders
11%
Arrestin Recruitment
11%
Selective Ligands
11%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
G Protein Coupled Receptor
77%
Dopamine 1 Receptor
32%
Guanine Nucleotide Binding Protein
29%
Retina S Antigen
27%
Drug Discovery
23%
Neurologic Disease
23%
Catechol
23%
Steroidogenic Acute Regulatory Protein
20%
Dopamine Receptor
18%
Receptor Agonist
17%
Serotonin
17%
Reactive Oxygen Metabolite
16%
Drug Development
16%
Mental Diseases
16%
Clinical Trial
14%
Progesterone
13%
Desensitization
13%
Drug Action
13%
Neurotransmitter
11%
High-Throughput Screening
11%
Antipsychotic
10%
Adenosine Triphosphate
10%
Huntington Chorea
10%
Pharmacokinetics
9%
Serotonin 2C Receptor
9%
Salvinorin A
9%
Tubulin
9%
Neuromedin U
9%
Leydig Cell Tumour
9%
Psychostimulant
9%
Drug Safety Assessment
9%
Cyclic AMP
9%
Dopamine 1 Receptor Stimulating Agent
9%
Sodium Channel
9%
Endotoxin
9%
Opiate Receptor
9%
DNA Topoisomerase Inhibitor
9%
Serotonin 2C Agonist
9%
Malignant Neoplasm
9%
Valvular Heart Disease
9%
Topotecan
9%
Fibroblast Growth Factor 14
9%
Lipopolysaccharide
9%
Benzamide Derivative
9%
Caveolin 1
9%
Atypical Antipsychotics
9%
Pharmaceutical Chemistry
7%
Hydrogen Peroxide
7%
Side Effect
7%
Neuroscience
G Protein Coupled Receptor
61%
Receptor
45%
Agonist
36%
5-HT2A Receptor
36%
Serotonin
29%
Mitochondrion
27%
Substance Abuse
24%
Lipid Raft
23%
In Vivo
23%
Antipsychotic
19%
Steroidogenic Acute Regulatory Protein
19%
Dopamine Receptor
18%
5-HT2C Receptor
18%
Caveolin 1
18%
Interstitial Cell
18%
Leydig Cell
18%
Reactive Oxygen Species
16%
Cyclic Adenosine Monophosphate
15%
Psychopathology
13%
Clozapine
13%
In Vitro
12%
Progesterone
12%
Neurotransmitter
11%
Mental Disorder
11%
Behavior (Neuroscience)
10%
Ribosomal S6 Kinase
10%
Caveolin
10%
Retina S Antigen
10%
Caveolae
10%
Internalization
10%
Scaffold Protein
10%
Angelman Syndrome
9%
Kalirin
9%
Neuromedin U
9%
Growth Factor
9%
Topoisomerase Inhibitor
9%
Kinase
9%
Topotecan
9%
Single-Nucleotide Polymorphism
9%
Receptor Tyrosine Kinase
9%
Microtubule
9%
Psychostimulant
9%
Green Fluorescent Protein
9%
Vertebral Column
9%
Neurite Outgrowth
9%
Cell Signaling
9%
Signal Transduction Pathway
9%
Neuronal Activity
9%
Adrenergic Stimulation
9%
Adenylyl Cyclase
9%
